FEATURES CRITERIA FOR THE DETECTION OF HEMOLYTIC DISEASE IN NEWBORNS
Keywords:
Previously effective methods of treatment, such as desensitization of antigens, plasmapheresis, hemosorption and intravenous administration of immunoglobulins, have only historical significanceAbstract
in our country, the number of pregnant women with rhesus sensibility every year remains unchanged and does not have a downward trend. This is due to insufficient prophylaxis after the termination of pregnancy (spontaneous abortion, ectopic pregnancy, the birth of a rhesus-positive fetus) with the use of immunoglobulin against antiretroviruses
References
1. Acar A. и др. Evaluation of the Results of Cordocentesis // Taiwan. J. Obstet. Gynecol. 2007. Т. 46. № 4. С. 405¬409.
2. Acevedo Gallegos S. и др. [Doppler ultrasound to detect Rh: a systematic review]. // Ginecol. Obstet. Mex. 2005. Т. 73. № 5. С. 234-44.
3. Aitken S.L., Tichy E.M. RhOD immune globulin products for prevention of alloimmunization during pregnancy // Am. J. Heal. Pharm. 2015. Т. 72. № 4. С. 267-276.
4. Bahado-Singh R. и др. Splenic artery Doppler peak systolic velocity predicts severe fetal anemia in rezus disease. // Am. J. Obstet. Gynecol. 2000. Т. 182. № 5. С. 1222-6.
5. Bhutani V.K. и др. Neonatal hyperbilirubinemia and Rezus disease of the newborn: incidence and impairment esti-mates for 2010 at regional and global levels. // Pediatr. Res. 2013. Т. 74 Suppl 1. № Suppl 1. С. 86-100.
6. Boggione C.T. и др. Genotyping approach for non-invasive foetal RHD detection in an admixed population. // Blood Transfus. 2017. Т. 15. № 1. С. 66-73.
7. Chilcott J. и др. A review of the clinical effectiveness and cost-effectiveness of routine anti-D prophylaxis for preg-nant women who are rezus -negative. // Health Technol. Assess. 2003. Т. 7. № 4. С. iii-62.
8. Chilcott J. и др. The economics of routine antenatal anti-D prophylaxis for pregnant women who are rezus negative // BJOG An Int. J. Obstet. Gynaecol. 2004. Т. 111. № 9. С. 903-907.
9. Committee on Practice Bulletins-Obstetrics. Practice Bulletin No. 181 // Obstet. Gynecol. 2017. Т. 130. № 2. С. e57- e70.
10. Correa M.D. и др. Influence of fetal anemia on fetal splenic artery Doppler in Rh-alloimmunized pregnancies // Fetal Diagn. Ther. 2009. Fetal Diagnosis and Therapy, 25(1),C 3-7.
11. Crowther C.A., Middleton P. Anti-D administration after childbirth for preventing Rezus alloimmunisation // Cochrane Database Syst. Rev. 1997. № 2.
12. Delaney M., Matthews D.C. Hemolytic disease of the fetus and newborn: managing the mother, fetus, and newborn // Hematology. 2015. Т. 2015. № 1. С. 146-151.
13. Donner C. и др. [Monitoring and treatment of fetal maternal allo-immunization. Role of cordocentesis]. // J. Gynecol. Obstet. Biol. Reprod. (Paris). 1994. Т. 23. № 8. С. 892-7.
14. Fung Kee Fung K. и др. Prevention of Rh alloimmunization. // J. Obstet. Gynaecol. Can. 2003. Т. 25. № 9. С. 765-73.
15. Grodnenskogo Gosudarstvennogo Meditsinskogo Universiteta Б.М., Журнал Гродненского государственного медицинского университета. Journal of Grodno State Medical University. Учреждение образования «Гродненский государственный медицинский университет», 2012.
16. Hadley A.G. Laboratory assays for predicting the severity of haemolytic disease of the fetus and newborn. // Transpl. Immunol. 2002. Т. 10. № 2-3. С. 191-8.
17. Karanth L. и др. Anti-D administration after spontaneous miscarriage for preventing Rezus alloimmunisation // Cochrane Database Syst. Rev. 2013. № 3.
18. Koby L. и др. Anti-D in Rh(D)-Negative Pregnant Women: Are At-Risk Pregnancies and Deliveries Receiving Ap-propriate Prophylaxis? // J. Obstet. Gynaecol. Canada. 2012. Т. 34. № 5. С. 429-435.
19. Kumar M., Umrawal T., Singh A. Middle cerebral artery Doppler reference centile charts for the prediction of fetal anemia in a population from India // Int. J. Gynecol. Obstet. 2017. Т. 139. № 3. С. 307-311.
20. Mari G. и др. Noninvasive Diagnosis by Doppler Ultrasonography of Fetal Anemia Due to Maternal Red-Cell Allo-immunization // N. Engl. J. Med. 2000. Т. 342. № 1. С. 9-14.
21. Mikulandra F. и др. [Advantages of preventing Rh isoimmunization]. // Jugosl. Ginekol. Perinatal. Т. 25. № 1-2. С. 29-34.
22. Oepkes D. и др. Doppler Ultrasonography versus Amniocentesis to Predict Fetal Anemia // N. Engl. J. Med. 2006. Т. 355. № 2. С. 156-164.
23. Okwundu C.I., Afolabi B .B. Intramuscular versus intravenous anti-D for preventing Rezus alloimmunization during pregnancy // Cochrane Database Syst. Rev. 2013. № 1.
24. Preis K., Ciach K., Swiatkowska-Freund M. [The risk of complications of diagnostic and therapeutic cordocentesis]. // Ginekol. Pol. 2004. Т. 75. № 10. С. 765-9.
25. Puech F. и др. [Complications of cordocentesis]. // J. Gynecol. Obstet. Biol. Reprod. (Paris). 1994. Т. 23. № 5. С. 480-4.
26. Roda J. и др. Isolated anaemia as a manifestation of Rh isoimmunisation. // BMJ Case Rep. 2012. Т. 2012.
27. Tongsong T. и др. Fetal Splenic Artery Peak Velocity (SPA-PSV) at Mid-Pregnancy as a Predictor of Hb Bart's Disease // Ultraschall der Medizin - Eur. J. Ultrasound. 2011. Т. 32. № S 01. С. 41-45.
28. Turner R.M. и др. Routine antenatal anti-D prophylaxis in women who are Rh (D) negative: meta-analyses adjusted for differences in study design and quality. // PLoS One. 2012. Т. 7. № 2. С. e30711.
29. Velkova E. Correlation between the amount of anti-D antibodies and IgG subclasses with severity of haemolytic disease of foetus and newborn // Maced. J. Med. Sci. 2015.
30. Wong K.S. и др. Antenatal immunoglobulin for fetal red blood cell alloimmunization // Cochrane Database Syst. Rev. 2013. № 5.
31. Zwingerman R. и др. Alloimmune Red Blood Cell Antibodies: Prevalence and Pathogenicity in a Canadian Prenatal Population. // J. Obstet. Gynaecol. Can. 2015. Т. 37. № 9. С. 784-790.
32. Александровна О.М., Николаевна К.Е., Владимировна К.Л. Mat'idita vKuzbasse. Некоммерческое партнерство «Издательский Дом «Медицина и просвещение», 2015.
33. Георгиевич К. А. School leadership & management. Taylor & Francis, 1997.
34. Ортикбаева Н.Т., Сирожиддинова Х.Н. Абдухалик-Заде Г.А. Часто встречаемые внутриутробные инфекции новорожденных. Журнал гепато-гастроэнтерологических исследований.ISSN 2181-1008. DOI 10.26739/2181-1008.№3.1 (том 11) 2021.
35. Сирожиддинова Х.Н. Ортикбоева Н. Т., Набиева Ш. М., Абдухалик-Заде Г.А. Иммунизация часто болеющих детей при лечении респираторных заболеваний. Uzacademia ilmiy-uslubiy jurnali vol 2, issue 1 (11), march 2021. 9-13 бет.
36. Сирожиддинова Х.Н. Усманова М. Ф., Тухтаева М. М., Абдухалик-Заде Г.А. Внутриутробное инфицирование как фактор развития перинатальной патологии. Uzacademia ilmiy-uslubiy jurnali vol 2, issue 1 (11), march 2021. 15-21 бет.
37. Сирожиддинова Х.Н. Тухтаева М. М., Алимова О. Б., Рустамова Х. Х. Ҳомила ичи инфекцияланишида перинатал патологиянинг аҳамияти. Eurasian journal of academic research Volume 1 Issue 8, November 2021 ISSN 2181-2020. On page 60-64.
38. Сирожиддинова Х.Н. Роль матерей в развитии перинатальной патологии и в формировании группы часто болеющих детей. Наука и мир Международный научный журнал 2015. - № 1 (17), Т 2. - С. 104-106.
39. Сирожиддинова Х.Н., Абдуллева М.Н. Клиническая значимость иммуномодулирующей терапии заболеваний органов дыхания у часто болеющих детей. MEDICUS Международный медицинский научный журнал, Волгоград, 2016, № 1 (7) С. 90-92.
40. Sirojiddinova X.N., Ikromova Z.X., Nabiyeva Sh.M., Ortikbayeva N.T., Abdullayeva G.D. Metabolic Changes Following Post-Hypoxic Complications in Newborns // International Journal of Current Research and Review DOI: http://dx.doi.org/10.31782/IJCRR.2020.122229. Scopus. On page 173-177.
